Corona Virus Disease 2019 and Paediatric Inflammatory Bowel Diseases: Global Experience and Provisional Guidance (March 2020) from the Paediatric IBD Porto Group of European Society of Paediatric Gastroenterology, Hepatology, and Nutrition.
Identifieur interne : 001159 ( Main/Corpus ); précédent : 001158; suivant : 001160Corona Virus Disease 2019 and Paediatric Inflammatory Bowel Diseases: Global Experience and Provisional Guidance (March 2020) from the Paediatric IBD Porto Group of European Society of Paediatric Gastroenterology, Hepatology, and Nutrition.
Auteurs : Dan Turner ; Ying Huang ; Javier Martín-De-Carpi ; Marina Aloi ; Gili Focht ; Ben Kang ; Ying Zhou ; Cesar Sanchez ; Michael D. Kappelman ; Holm H. Uhlig ; Gemma Pujol-Muncunill ; Oren Ledder ; Paolo Lionetti ; Jorge Amil Dias ; Frank M. Ruemmele ; Richard K. RussellSource :
- Journal of pediatric gastroenterology and nutrition [ 1536-4801 ] ; 2020.
English descriptors
- KwdEn :
- Adolescent (MeSH), Adult (MeSH), Betacoronavirus (MeSH), Child (MeSH), Consensus (MeSH), Coronavirus Infections (chemically induced), Coronavirus Infections (complications), Coronavirus Infections (epidemiology), Coronavirus Infections (therapy), Health Care Surveys (MeSH), Humans (MeSH), Immunologic Factors (adverse effects), Inflammatory Bowel Diseases (complications), Inflammatory Bowel Diseases (epidemiology), Inflammatory Bowel Diseases (therapy), Pandemics (MeSH), Pneumonia, Viral (chemically induced), Pneumonia, Viral (complications), Pneumonia, Viral (epidemiology), Pneumonia, Viral (therapy), Severity of Illness Index (MeSH).
- MESH :
- chemical , adverse effects : Immunologic Factors.
- chemically induced : Coronavirus Infections, Pneumonia, Viral.
- complications : Coronavirus Infections, Inflammatory Bowel Diseases, Pneumonia, Viral.
- epidemiology : Coronavirus Infections, Inflammatory Bowel Diseases, Pneumonia, Viral.
- therapy : Coronavirus Infections, Inflammatory Bowel Diseases, Pneumonia, Viral.
- Adolescent, Adult, Betacoronavirus, Child, Consensus, Health Care Surveys, Humans, Pandemics, Severity of Illness Index.
Abstract
INTRODUCTION
With the current coronavirus disease 2019 (COVID-19) pandemic, concerns have been raised about the risk to children with inflammatory bowel diseases (IBD). We aimed to collate global experience and provide provisional guidance for managing paediatric IBD (PIBD) in the era of COVID-19.
METHODS
An electronic reporting system of children with IBD infected with SARS-CoV-2 has been circulated among 102 PIBD centres affiliated with the Porto and Interest-group of ESPGHAN. A survey has been completed by major PIBD centres in China and South-Korea to explore management during the pandemic. A third survey collected current practice of PIBD treatment. Finally, guidance points for practice have been formulated and voted upon by 37 PIBD authors and Porto group members.
RESULTS
Eight PIBD children had COVID-19 globally, all with mild infection without needing hospitalization despite treatment with immunomodulators and/or biologics. No cases have been reported in China and South Korea but biologic treatment has been delayed in 79 children, of whom 17 (22%) had exacerbation of their IBD. Among the Porto group members, face-to-face appointments were often replaced by remote consultations but almost all did not change current IBD treatment. Ten guidance points for clinicians caring for PIBD patients in epidemic areas have been endorsed with consensus rate of 92% to 100%.
CONCLUSIONS
Preliminary data for PIBD patients during COVID-19 outbreak are reassuring. Standard IBD treatments including biologics should continue at present through the pandemic, especially in children who generally have more severe IBD course on one hand, and milder SARS-CoV-2 infection on the other.
DOI: 10.1097/MPG.0000000000002729
PubMed: 32443020
PubMed Central: PMC7273950
Links to Exploration step
pubmed:32443020Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Corona Virus Disease 2019 and Paediatric Inflammatory Bowel Diseases: Global Experience and Provisional Guidance (March 2020) from the Paediatric IBD Porto Group of European Society of Paediatric Gastroenterology, Hepatology, and Nutrition.</title><author><name sortKey="Turner, Dan" sort="Turner, Dan" uniqKey="Turner D" first="Dan" last="Turner">Dan Turner</name><affiliation><nlm:affiliation>Shaare Zedek Medical Center, The Hebrew University of Jerusalem, Jerusalem, Israel.</nlm:affiliation></affiliation></author><author><name sortKey="Huang, Ying" sort="Huang, Ying" uniqKey="Huang Y" first="Ying" last="Huang">Ying Huang</name><affiliation><nlm:affiliation>Department of Gastroenterology, National Children's Medical Center, Children's Hospital of Fudan University, Shanghai, China.</nlm:affiliation></affiliation></author><author><name sortKey="Martin De Carpi, Javier" sort="Martin De Carpi, Javier" uniqKey="Martin De Carpi J" first="Javier" last="Martín-De-Carpi">Javier Martín-De-Carpi</name><affiliation><nlm:affiliation>Hospital Sant Joan de Déu, Barcelona, Spain.</nlm:affiliation></affiliation></author><author><name sortKey="Aloi, Marina" sort="Aloi, Marina" uniqKey="Aloi M" first="Marina" last="Aloi">Marina Aloi</name><affiliation><nlm:affiliation>Pediatric Gastroenterology and Liver Unit, Sapienza University of Rome, Rome, Italy.</nlm:affiliation></affiliation></author><author><name sortKey="Focht, Gili" sort="Focht, Gili" uniqKey="Focht G" first="Gili" last="Focht">Gili Focht</name><affiliation><nlm:affiliation>Shaare Zedek Medical Center, The Hebrew University of Jerusalem, Jerusalem, Israel.</nlm:affiliation></affiliation></author><author><name sortKey="Kang, Ben" sort="Kang, Ben" uniqKey="Kang B" first="Ben" last="Kang">Ben Kang</name><affiliation><nlm:affiliation>Kyungpook National University Children's Hospital, School of Medicine, Kyungpook National University, Daegu, Korea.</nlm:affiliation></affiliation></author><author><name sortKey="Zhou, Ying" sort="Zhou, Ying" uniqKey="Zhou Y" first="Ying" last="Zhou">Ying Zhou</name><affiliation><nlm:affiliation>Department of Gastroenterology, National Children's Medical Center, Children's Hospital of Fudan University, Shanghai, China.</nlm:affiliation></affiliation></author><author><name sortKey="Sanchez, Cesar" sort="Sanchez, Cesar" uniqKey="Sanchez C" first="Cesar" last="Sanchez">Cesar Sanchez</name><affiliation><nlm:affiliation>Pediatric Gastrointestinal Unit H.G.U. Gregorio Maranon, Madrid, Spain.</nlm:affiliation></affiliation></author><author><name sortKey="Kappelman, Michael D" sort="Kappelman, Michael D" uniqKey="Kappelman M" first="Michael D" last="Kappelman">Michael D. Kappelman</name><affiliation><nlm:affiliation>Pediatric Gastroenterology, University of North Carolina at Chapel Hill, Chapel Hill, NC.</nlm:affiliation></affiliation></author><author><name sortKey="Uhlig, Holm H" sort="Uhlig, Holm H" uniqKey="Uhlig H" first="Holm H" last="Uhlig">Holm H. Uhlig</name><affiliation><nlm:affiliation>Translational Gastroenterology Unit, University of Oxford, Department of Paediatrics, John Radcliffe Hospital, University of Oxford, Biomedical Research Center Oxford, Oxford, UK.</nlm:affiliation></affiliation></author><author><name sortKey="Pujol Muncunill, Gemma" sort="Pujol Muncunill, Gemma" uniqKey="Pujol Muncunill G" first="Gemma" last="Pujol-Muncunill">Gemma Pujol-Muncunill</name><affiliation><nlm:affiliation>Hospital Sant Joan de Déu, Barcelona, Spain.</nlm:affiliation></affiliation></author><author><name sortKey="Ledder, Oren" sort="Ledder, Oren" uniqKey="Ledder O" first="Oren" last="Ledder">Oren Ledder</name><affiliation><nlm:affiliation>Shaare Zedek Medical Center, The Hebrew University of Jerusalem, Jerusalem, Israel.</nlm:affiliation></affiliation></author><author><name sortKey="Lionetti, Paolo" sort="Lionetti, Paolo" uniqKey="Lionetti P" first="Paolo" last="Lionetti">Paolo Lionetti</name><affiliation><nlm:affiliation>Departement NEUROFARBA - University of Florence - Meyer children's Hospital - Florence, Florence, Italy.</nlm:affiliation></affiliation></author><author><name sortKey="Dias, Jorge Amil" sort="Dias, Jorge Amil" uniqKey="Dias J" first="Jorge Amil" last="Dias">Jorge Amil Dias</name><affiliation><nlm:affiliation>Pediatric Gastroenterology, Centro Hospitalar Universitário S. João, Porto, Portugal.</nlm:affiliation></affiliation></author><author><name sortKey="Ruemmele, Frank M" sort="Ruemmele, Frank M" uniqKey="Ruemmele F" first="Frank M" last="Ruemmele">Frank M. Ruemmele</name><affiliation><nlm:affiliation>Université Paris Descartes, Sorbonne Paris Cité, APHP, Hôpital Necker Enfants Malades, Paris, France.</nlm:affiliation></affiliation></author><author><name sortKey="Russell, Richard K" sort="Russell, Richard K" uniqKey="Russell R" first="Richard K" last="Russell">Richard K. Russell</name><affiliation><nlm:affiliation>Department of Paediatric Gastroenterology, The Royal Hospital for Sick Children, Edinburgh, UK.</nlm:affiliation></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2020">2020</date><idno type="RBID">pubmed:32443020</idno><idno type="pmid">32443020</idno><idno type="doi">10.1097/MPG.0000000000002729</idno><idno type="pmc">PMC7273950</idno><idno type="wicri:Area/Main/Corpus">001159</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">001159</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Corona Virus Disease 2019 and Paediatric Inflammatory Bowel Diseases: Global Experience and Provisional Guidance (March 2020) from the Paediatric IBD Porto Group of European Society of Paediatric Gastroenterology, Hepatology, and Nutrition.</title><author><name sortKey="Turner, Dan" sort="Turner, Dan" uniqKey="Turner D" first="Dan" last="Turner">Dan Turner</name><affiliation><nlm:affiliation>Shaare Zedek Medical Center, The Hebrew University of Jerusalem, Jerusalem, Israel.</nlm:affiliation></affiliation></author><author><name sortKey="Huang, Ying" sort="Huang, Ying" uniqKey="Huang Y" first="Ying" last="Huang">Ying Huang</name><affiliation><nlm:affiliation>Department of Gastroenterology, National Children's Medical Center, Children's Hospital of Fudan University, Shanghai, China.</nlm:affiliation></affiliation></author><author><name sortKey="Martin De Carpi, Javier" sort="Martin De Carpi, Javier" uniqKey="Martin De Carpi J" first="Javier" last="Martín-De-Carpi">Javier Martín-De-Carpi</name><affiliation><nlm:affiliation>Hospital Sant Joan de Déu, Barcelona, Spain.</nlm:affiliation></affiliation></author><author><name sortKey="Aloi, Marina" sort="Aloi, Marina" uniqKey="Aloi M" first="Marina" last="Aloi">Marina Aloi</name><affiliation><nlm:affiliation>Pediatric Gastroenterology and Liver Unit, Sapienza University of Rome, Rome, Italy.</nlm:affiliation></affiliation></author><author><name sortKey="Focht, Gili" sort="Focht, Gili" uniqKey="Focht G" first="Gili" last="Focht">Gili Focht</name><affiliation><nlm:affiliation>Shaare Zedek Medical Center, The Hebrew University of Jerusalem, Jerusalem, Israel.</nlm:affiliation></affiliation></author><author><name sortKey="Kang, Ben" sort="Kang, Ben" uniqKey="Kang B" first="Ben" last="Kang">Ben Kang</name><affiliation><nlm:affiliation>Kyungpook National University Children's Hospital, School of Medicine, Kyungpook National University, Daegu, Korea.</nlm:affiliation></affiliation></author><author><name sortKey="Zhou, Ying" sort="Zhou, Ying" uniqKey="Zhou Y" first="Ying" last="Zhou">Ying Zhou</name><affiliation><nlm:affiliation>Department of Gastroenterology, National Children's Medical Center, Children's Hospital of Fudan University, Shanghai, China.</nlm:affiliation></affiliation></author><author><name sortKey="Sanchez, Cesar" sort="Sanchez, Cesar" uniqKey="Sanchez C" first="Cesar" last="Sanchez">Cesar Sanchez</name><affiliation><nlm:affiliation>Pediatric Gastrointestinal Unit H.G.U. Gregorio Maranon, Madrid, Spain.</nlm:affiliation></affiliation></author><author><name sortKey="Kappelman, Michael D" sort="Kappelman, Michael D" uniqKey="Kappelman M" first="Michael D" last="Kappelman">Michael D. Kappelman</name><affiliation><nlm:affiliation>Pediatric Gastroenterology, University of North Carolina at Chapel Hill, Chapel Hill, NC.</nlm:affiliation></affiliation></author><author><name sortKey="Uhlig, Holm H" sort="Uhlig, Holm H" uniqKey="Uhlig H" first="Holm H" last="Uhlig">Holm H. Uhlig</name><affiliation><nlm:affiliation>Translational Gastroenterology Unit, University of Oxford, Department of Paediatrics, John Radcliffe Hospital, University of Oxford, Biomedical Research Center Oxford, Oxford, UK.</nlm:affiliation></affiliation></author><author><name sortKey="Pujol Muncunill, Gemma" sort="Pujol Muncunill, Gemma" uniqKey="Pujol Muncunill G" first="Gemma" last="Pujol-Muncunill">Gemma Pujol-Muncunill</name><affiliation><nlm:affiliation>Hospital Sant Joan de Déu, Barcelona, Spain.</nlm:affiliation></affiliation></author><author><name sortKey="Ledder, Oren" sort="Ledder, Oren" uniqKey="Ledder O" first="Oren" last="Ledder">Oren Ledder</name><affiliation><nlm:affiliation>Shaare Zedek Medical Center, The Hebrew University of Jerusalem, Jerusalem, Israel.</nlm:affiliation></affiliation></author><author><name sortKey="Lionetti, Paolo" sort="Lionetti, Paolo" uniqKey="Lionetti P" first="Paolo" last="Lionetti">Paolo Lionetti</name><affiliation><nlm:affiliation>Departement NEUROFARBA - University of Florence - Meyer children's Hospital - Florence, Florence, Italy.</nlm:affiliation></affiliation></author><author><name sortKey="Dias, Jorge Amil" sort="Dias, Jorge Amil" uniqKey="Dias J" first="Jorge Amil" last="Dias">Jorge Amil Dias</name><affiliation><nlm:affiliation>Pediatric Gastroenterology, Centro Hospitalar Universitário S. João, Porto, Portugal.</nlm:affiliation></affiliation></author><author><name sortKey="Ruemmele, Frank M" sort="Ruemmele, Frank M" uniqKey="Ruemmele F" first="Frank M" last="Ruemmele">Frank M. Ruemmele</name><affiliation><nlm:affiliation>Université Paris Descartes, Sorbonne Paris Cité, APHP, Hôpital Necker Enfants Malades, Paris, France.</nlm:affiliation></affiliation></author><author><name sortKey="Russell, Richard K" sort="Russell, Richard K" uniqKey="Russell R" first="Richard K" last="Russell">Richard K. Russell</name><affiliation><nlm:affiliation>Department of Paediatric Gastroenterology, The Royal Hospital for Sick Children, Edinburgh, UK.</nlm:affiliation></affiliation></author></analytic><series><title level="j">Journal of pediatric gastroenterology and nutrition</title><idno type="eISSN">1536-4801</idno><imprint><date when="2020" type="published">2020</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adolescent (MeSH)</term><term>Adult (MeSH)</term><term>Betacoronavirus (MeSH)</term><term>Child (MeSH)</term><term>Consensus (MeSH)</term><term>Coronavirus Infections (chemically induced)</term><term>Coronavirus Infections (complications)</term><term>Coronavirus Infections (epidemiology)</term><term>Coronavirus Infections (therapy)</term><term>Health Care Surveys (MeSH)</term><term>Humans (MeSH)</term><term>Immunologic Factors (adverse effects)</term><term>Inflammatory Bowel Diseases (complications)</term><term>Inflammatory Bowel Diseases (epidemiology)</term><term>Inflammatory Bowel Diseases (therapy)</term><term>Pandemics (MeSH)</term><term>Pneumonia, Viral (chemically induced)</term><term>Pneumonia, Viral (complications)</term><term>Pneumonia, Viral (epidemiology)</term><term>Pneumonia, Viral (therapy)</term><term>Severity of Illness Index (MeSH)</term></keywords><keywords scheme="MESH" type="chemical" qualifier="adverse effects" xml:lang="en"><term>Immunologic Factors</term></keywords><keywords scheme="MESH" qualifier="chemically induced" xml:lang="en"><term>Coronavirus Infections</term><term>Pneumonia, Viral</term></keywords><keywords scheme="MESH" qualifier="complications" xml:lang="en"><term>Coronavirus Infections</term><term>Inflammatory Bowel Diseases</term><term>Pneumonia, Viral</term></keywords><keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>Coronavirus Infections</term><term>Inflammatory Bowel Diseases</term><term>Pneumonia, Viral</term></keywords><keywords scheme="MESH" qualifier="therapy" xml:lang="en"><term>Coronavirus Infections</term><term>Inflammatory Bowel Diseases</term><term>Pneumonia, Viral</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Adolescent</term><term>Adult</term><term>Betacoronavirus</term><term>Child</term><term>Consensus</term><term>Health Care Surveys</term><term>Humans</term><term>Pandemics</term><term>Severity of Illness Index</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en"><p><b>INTRODUCTION</b></p><p>With the current coronavirus disease 2019 (COVID-19) pandemic, concerns have been raised about the risk to children with inflammatory bowel diseases (IBD). We aimed to collate global experience and provide provisional guidance for managing paediatric IBD (PIBD) in the era of COVID-19.</p></div><div type="abstract" xml:lang="en"><p><b>METHODS</b></p><p>An electronic reporting system of children with IBD infected with SARS-CoV-2 has been circulated among 102 PIBD centres affiliated with the Porto and Interest-group of ESPGHAN. A survey has been completed by major PIBD centres in China and South-Korea to explore management during the pandemic. A third survey collected current practice of PIBD treatment. Finally, guidance points for practice have been formulated and voted upon by 37 PIBD authors and Porto group members.</p></div><div type="abstract" xml:lang="en"><p><b>RESULTS</b></p><p>Eight PIBD children had COVID-19 globally, all with mild infection without needing hospitalization despite treatment with immunomodulators and/or biologics. No cases have been reported in China and South Korea but biologic treatment has been delayed in 79 children, of whom 17 (22%) had exacerbation of their IBD. Among the Porto group members, face-to-face appointments were often replaced by remote consultations but almost all did not change current IBD treatment. Ten guidance points for clinicians caring for PIBD patients in epidemic areas have been endorsed with consensus rate of 92% to 100%.</p></div><div type="abstract" xml:lang="en"><p><b>CONCLUSIONS</b></p><p>Preliminary data for PIBD patients during COVID-19 outbreak are reassuring. Standard IBD treatments including biologics should continue at present through the pandemic, especially in children who generally have more severe IBD course on one hand, and milder SARS-CoV-2 infection on the other.</p></div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">32443020</PMID><DateCompleted><Year>2020</Year><Month>06</Month><Day>05</Day></DateCompleted><DateRevised><Year>2020</Year><Month>06</Month><Day>06</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1536-4801</ISSN><JournalIssue CitedMedium="Internet"><Volume>70</Volume><Issue>6</Issue><PubDate><Year>2020</Year><Month>06</Month></PubDate></JournalIssue><Title>Journal of pediatric gastroenterology and nutrition</Title><ISOAbbreviation>J. Pediatr. Gastroenterol. Nutr.</ISOAbbreviation></Journal><ArticleTitle>Corona Virus Disease 2019 and Paediatric Inflammatory Bowel Diseases: Global Experience and Provisional Guidance (March 2020) from the Paediatric IBD Porto Group of European Society of Paediatric Gastroenterology, Hepatology, and Nutrition.</ArticleTitle><Pagination><MedlinePgn>727-733</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1097/MPG.0000000000002729</ELocationID><Abstract><AbstractText Label="INTRODUCTION">With the current coronavirus disease 2019 (COVID-19) pandemic, concerns have been raised about the risk to children with inflammatory bowel diseases (IBD). We aimed to collate global experience and provide provisional guidance for managing paediatric IBD (PIBD) in the era of COVID-19.</AbstractText><AbstractText Label="METHODS">An electronic reporting system of children with IBD infected with SARS-CoV-2 has been circulated among 102 PIBD centres affiliated with the Porto and Interest-group of ESPGHAN. A survey has been completed by major PIBD centres in China and South-Korea to explore management during the pandemic. A third survey collected current practice of PIBD treatment. Finally, guidance points for practice have been formulated and voted upon by 37 PIBD authors and Porto group members.</AbstractText><AbstractText Label="RESULTS">Eight PIBD children had COVID-19 globally, all with mild infection without needing hospitalization despite treatment with immunomodulators and/or biologics. No cases have been reported in China and South Korea but biologic treatment has been delayed in 79 children, of whom 17 (22%) had exacerbation of their IBD. Among the Porto group members, face-to-face appointments were often replaced by remote consultations but almost all did not change current IBD treatment. Ten guidance points for clinicians caring for PIBD patients in epidemic areas have been endorsed with consensus rate of 92% to 100%.</AbstractText><AbstractText Label="CONCLUSIONS">Preliminary data for PIBD patients during COVID-19 outbreak are reassuring. Standard IBD treatments including biologics should continue at present through the pandemic, especially in children who generally have more severe IBD course on one hand, and milder SARS-CoV-2 infection on the other.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Turner</LastName><ForeName>Dan</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Shaare Zedek Medical Center, The Hebrew University of Jerusalem, Jerusalem, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huang</LastName><ForeName>Ying</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Gastroenterology, National Children's Medical Center, Children's Hospital of Fudan University, Shanghai, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Martín-de-Carpi</LastName><ForeName>Javier</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Hospital Sant Joan de Déu, Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Aloi</LastName><ForeName>Marina</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Pediatric Gastroenterology and Liver Unit, Sapienza University of Rome, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Focht</LastName><ForeName>Gili</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Shaare Zedek Medical Center, The Hebrew University of Jerusalem, Jerusalem, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kang</LastName><ForeName>Ben</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Kyungpook National University Children's Hospital, School of Medicine, Kyungpook National University, Daegu, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhou</LastName><ForeName>Ying</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Gastroenterology, National Children's Medical Center, Children's Hospital of Fudan University, Shanghai, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sanchez</LastName><ForeName>Cesar</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Pediatric Gastrointestinal Unit H.G.U. Gregorio Maranon, Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kappelman</LastName><ForeName>Michael D</ForeName><Initials>MD</Initials><AffiliationInfo><Affiliation>Pediatric Gastroenterology, University of North Carolina at Chapel Hill, Chapel Hill, NC.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Uhlig</LastName><ForeName>Holm H</ForeName><Initials>HH</Initials><AffiliationInfo><Affiliation>Translational Gastroenterology Unit, University of Oxford, Department of Paediatrics, John Radcliffe Hospital, University of Oxford, Biomedical Research Center Oxford, Oxford, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pujol-Muncunill</LastName><ForeName>Gemma</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Hospital Sant Joan de Déu, Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ledder</LastName><ForeName>Oren</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Shaare Zedek Medical Center, The Hebrew University of Jerusalem, Jerusalem, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lionetti</LastName><ForeName>Paolo</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Departement NEUROFARBA - University of Florence - Meyer children's Hospital - Florence, Florence, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dias</LastName><ForeName>Jorge Amil</ForeName><Initials>JA</Initials><AffiliationInfo><Affiliation>Pediatric Gastroenterology, Centro Hospitalar Universitário S. João, Porto, Portugal.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ruemmele</LastName><ForeName>Frank M</ForeName><Initials>FM</Initials><AffiliationInfo><Affiliation>Université Paris Descartes, Sorbonne Paris Cité, APHP, Hôpital Necker Enfants Malades, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Russell</LastName><ForeName>Richard K</ForeName><Initials>RK</Initials><AffiliationInfo><Affiliation>Department of Paediatric Gastroenterology, The Royal Hospital for Sick Children, Edinburgh, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>Paediatric IBD Porto group of ESPGHAN</CollectiveName></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Pediatr Gastroenterol Nutr</MedlineTA><NlmUniqueID>8211545</NlmUniqueID><ISSNLinking>0277-2116</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007155">Immunologic Factors</NameOfSubstance></Chemical></ChemicalList><SupplMeshList><SupplMeshName Type="Disease" UI="C000657245">COVID-19</SupplMeshName><SupplMeshName Type="Organism" UI="C000656484">severe acute respiratory syndrome coronavirus 2</SupplMeshName></SupplMeshList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000073640" MajorTopicYN="N">Betacoronavirus</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D032921" MajorTopicYN="N">Consensus</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018352" MajorTopicYN="N">Coronavirus Infections</DescriptorName><QualifierName UI="Q000139" MajorTopicYN="N">chemically induced</QualifierName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019538" MajorTopicYN="N">Health Care Surveys</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007155" MajorTopicYN="N">Immunologic Factors</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015212" MajorTopicYN="N">Inflammatory Bowel Diseases</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011024" MajorTopicYN="N">Pneumonia, Viral</DescriptorName><QualifierName UI="Q000139" MajorTopicYN="N">chemically induced</QualifierName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012720" MajorTopicYN="N">Severity of Illness Index</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>5</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>5</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>6</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32443020</ArticleId><ArticleId IdType="doi">10.1097/MPG.0000000000002729</ArticleId><ArticleId IdType="pii">00005176-202006000-00003</ArticleId><ArticleId IdType="pmc">PMC7273950</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Nature. 2020 Mar;579(7798):270-273</Citation><ArticleIdList><ArticleId IdType="pubmed">32015507</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Gastroenterol Hepatol. 2020 Jun;18(7):1409-1411</Citation><ArticleIdList><ArticleId IdType="pubmed">32197957</ArticleId></ArticleIdList></Reference><Reference><Citation>World J Pediatr. 2020 Mar 19;:</Citation><ArticleIdList><ArticleId IdType="pubmed">32193831</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet. 2020 Feb 29;395(10225):683-684</Citation><ArticleIdList><ArticleId IdType="pubmed">32122468</ArticleId></ArticleIdList></Reference><Reference><Citation>Cell Discov. 2020 Mar 16;6:14</Citation><ArticleIdList><ArticleId IdType="pubmed">32194980</ArticleId></ArticleIdList></Reference><Reference><Citation>Gastroenterology. 2020 May;158(6):1518-1519</Citation><ArticleIdList><ArticleId IdType="pubmed">32142785</ArticleId></ArticleIdList></Reference><Reference><Citation>Pediatr Infect Dis J. 2020 May;39(5):355-368</Citation><ArticleIdList><ArticleId IdType="pubmed">32310621</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Infect Dis. 2020 Mar 12;:</Citation><ArticleIdList><ArticleId IdType="pubmed">32161940</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet Gastroenterol Hepatol. 2020 May;5(5):425-427</Citation><ArticleIdList><ArticleId IdType="pubmed">32171057</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2020 Apr 23;382(17):1663-1665</Citation><ArticleIdList><ArticleId IdType="pubmed">32187458</ArticleId></ArticleIdList></Reference><Reference><Citation>Liver Transpl. 2020 Jun;26(6):832-834</Citation><ArticleIdList><ArticleId IdType="pubmed">32196933</ArticleId></ArticleIdList></Reference><Reference><Citation>Signal Transduct Target Ther. 2020 Feb 21;5(1):18</Citation><ArticleIdList><ArticleId IdType="pubmed">32296012</ArticleId></ArticleIdList></Reference><Reference><Citation>Mil Med Res. 2020 Feb 6;7(1):4</Citation><ArticleIdList><ArticleId IdType="pubmed">32029004</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet. 2020 Feb 15;395(10223):473-475</Citation><ArticleIdList><ArticleId IdType="pubmed">32043983</ArticleId></ArticleIdList></Reference><Reference><Citation>Antiviral Res. 2015 Mar;115:9-16</Citation><ArticleIdList><ArticleId IdType="pubmed">25542975</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet. 2020 Mar 28;395(10229):1033-1034</Citation><ArticleIdList><ArticleId IdType="pubmed">32192578</ArticleId></ArticleIdList></Reference><Reference><Citation>J Heart Lung Transplant. 2020 May;39(5):405-407</Citation><ArticleIdList><ArticleId IdType="pubmed">32362390</ArticleId></ArticleIdList></Reference><Reference><Citation>J Korean Med Sci. 2020 Mar 16;35(10):e112</Citation><ArticleIdList><ArticleId IdType="pubmed">32174069</ArticleId></ArticleIdList></Reference><Reference><Citation>Gastroenterology. 2020 May;158(6):1831-1833.e3</Citation><ArticleIdList><ArticleId IdType="pubmed">32142773</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></pubmed></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidFranceV1/Data/Main/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001159 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Corpus/biblio.hfd -nk 001159 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= CovidFranceV1
|flux= Main
|étape= Corpus
|type= RBID
|clé= pubmed:32443020
|texte= Corona Virus Disease 2019 and Paediatric Inflammatory Bowel Diseases: Global Experience and Provisional Guidance (March 2020) from the Paediatric IBD Porto Group of European Society of Paediatric Gastroenterology, Hepatology, and Nutrition.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Corpus/RBID.i -Sk "pubmed:32443020" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Corpus/biblio.hfd \
| NlmPubMed2Wicri -a CovidFranceV1
| This area was generated with Dilib version V0.6.37. |  |